文献
J-GLOBAL ID:201702227793375078
整理番号:17A0378671
ビルダグリプチンはグリメピリドと比較して2型糖尿病患者の血漿ストロマ細胞由来因子-1αを減少させる
Vildagliptin reduces plasma stromal cell-derived factor-1α in patients with type 2 diabetes compared with glimepiride
著者 (7件):
Park Kyeong Seon
(Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea)
,
Kwak SooHeon
(Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea)
,
Cho Young Min
(Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea)
,
Park Kyong Soo
(Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea)
,
Jang Hak C
(Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea)
,
Kim Seong Yeon
(Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea)
,
Jung Hye Seung
(Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea)
資料名:
Journal of Diabetes Investigation (Web)
(Journal of Diabetes Investigation (Web))
巻:
8
号:
2
ページ:
218-226
発行年:
2017年
JST資料番号:
U0507A
ISSN:
2040-1124
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)